通过蝶效应解开慢性心血管和脏疾病
Dimitri Bedo1,2, Thomas Beaudrey1,3, Nans Florens1,3
1Nephrology Department, Hopitaux Universitaires de Strasbourg, F-67091 Strasbourg, France.
Diagnostics (Basel, Switzerland)
|March 13, 2024
概括
慢性心血管和脏疾病 (CCKD) 中的"蝶效应"显示了急性损伤和心力衰竭如何相互恶化. 新的疗法和目标为管理这种复杂,交织在一起的疾病提供了希望.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 翻译医学是一种翻译医学.
背景情况:
- 慢性心血管和脏疾病 (CCKD) 是一个日益严重的医疗保健问题.
- 肺结核病涉及心脏和脏系统之间的复杂相互作用.
- "蝶效应"描述了一个系统中的急性器官损伤如何逐渐损害另一个系统.
研究的目的:
- 探索CCKD中"蝶效应"的病理生理学.
- 审查目前和新兴的CCKD治疗方法.
- 为了确定CCKD的新型治疗点.
主要方法:
- 关于CCKD病理生理学的文献综述.
- 分析急性损伤 (AKI) 和心力衰竭 (HF) 之间的相互作用.
- 评估新兴治疗剂和新目标.
主要成果:
- 在CCKD中,AKI和HF显著加剧了彼此.
- 列宁- ангиотензин- алдостерон系统 (RAAS) 抑制剂,SGLT2 抑制剂和GLP1 激动剂显示出治疗的前景.
- 加列-3抑制和IL33/ST2通路调节是潜在的新疗法途径.
结论:
- 认识到心脏和功能障碍的相互联系对于CCKD管理至关重要.
- 新兴的疗法和目标为改变CCKD的过程提供了新的策略.
- 这种多面综合征需要综合治疗方法.
相关概念视频
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Heart Failure Drugs: Diuretics
375
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
375
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K


